Natural killer type 2 bias in remission of multiple sclerosis
about
The innate immune system in demyelinating diseaseNatural killer cells and autoimmunityFunctional Significance of CD57 Expression on Human NK Cells and Relevance to DiseaseAlterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP).Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab')2Role of the innate immune system in the pathogenesis of multiple sclerosis.Natural killer cells control a T-helper 1 response in patients with Behçet's disease.NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome.The natural killer cell -- friend or foe in autoimmune disease?Tolerogen-induced interferon-producing killer dendritic cells (IKDCs) protect against EAE.Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis.The role of NK cells and NK cell receptors in autoimmune disease.Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation.The immunogenetics of multiple sclerosis: A comprehensive review.The role of natural killer cells in curbing neuroinflammationReciprocal regulation between natural killer cells and autoreactive T cells.Altered gene expression and function of peripheral blood natural killer cells in children with autism.Natural killer cells and their receptors in multiple sclerosis.Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS.Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination.NK cell autoreactivity and autoimmune diseases.Natural killer cells in human autoimmune disordersNatural killer cells: versatile roles in autoimmune and infectious diseases.Natural killer cells as indispensable players and therapeutic targets in autoimmunity.Initial immunopathogenesis of multiple sclerosis: innate immune response.Regulatory Functions of Natural Killer Cells in Multiple Sclerosis.Analysis of circulating T gamma/delta lymphocytes and CD16/56 cell populations in children and adolescents with Graves' disease.Season of birth and not vitamin D receptor promoter polymorphisms is a risk factor for multiple sclerosis.Divergence in NK cell and cyclic AMP regulation of T cell CD40L expression in asthmatic subjects.The immunogenetics of neurological disease.[Role of vitamin D in the physiopathology of neurodegenerative diseases].Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis.Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis.Natural killer (NK) cell deficit in coronary artery disease: no aberrations in phenotype but sustained reduction of NK cells is associated with low-grade inflammation.
P2860
Q24597958-8AFFF17E-6337-4C61-B931-7D9969BF8557Q24793284-BD2D016F-A069-4318-B2DF-5B1461E4A3EFQ27022458-CB90F2C4-ADAA-448E-84DA-C734805C718DQ33412876-0816F26C-0EA6-4F3F-8F0F-F9A225EECEF0Q33664396-2BE9384C-BD3F-4EF2-9F61-A9EDF3F1B336Q33787624-8C398D7A-B3CA-477C-A746-1DF6EA7016A4Q34027448-B3083513-925B-4B9B-98B0-DD9FDCB39E1CQ34541173-FA5F59B6-EE05-40A3-96EB-F60A51C02D42Q34613914-5B1CF186-333A-435A-A71E-4C321BA617FDQ35610755-0FF7EAB2-B67F-4438-8EA3-5527445B8F8DQ35817615-8992C722-464D-4A34-B56A-26259D7CDA04Q35855834-AFCEE549-A56C-489B-9A9E-5BB0F0DB5E22Q36385464-AD33B6C1-1E78-45F6-8329-3FE2BFDFA411Q36394834-DC30031B-A18E-43C9-AB58-9B38386DB5DFQ36407758-85E7E734-FFCF-4760-8741-70F8A2F8064EQ36602589-CA26C321-233A-43B4-A205-BC5CE4F6883EQ37085371-8FC5EED0-B15C-438A-9B5C-624C3861AA41Q37124504-154ABCA2-3255-4E2E-97BB-CB8A4023A9FAQ37128253-6A4CDE6D-A716-47B4-8FDA-532B55C21C12Q37128257-546B4D1A-A8FC-47BB-8AAF-1E9F5C54AFB9Q37552129-7A7F4F44-00B8-4F55-812C-6C55F4A4C942Q37690952-F49B7BF4-FCF2-4C0C-9929-80A780AA85CFQ37754682-0ABAFA2F-A474-4B56-8392-063551559B5BQ37779313-334678E7-7F37-4ED5-9B5B-F3DD4B59ED8DQ38156767-57F886D7-4CF4-42D2-8E65-C399C6762ABAQ39032832-48B04EE1-4E63-4955-9A8F-A67AC8526B9DQ39650071-AC5970BD-938D-4160-A0EF-48D44B7A238CQ43228864-4F708E98-9514-4818-837D-1332A6859ACEQ44576446-5FBB821B-3D30-4565-BE1C-6388FEEB2400Q46094020-ABF28342-6786-46CA-8021-4656F6330D40Q48854619-493A295A-2E00-436C-99DD-01BA3723725FQ50982454-1BD7516E-28EB-4EB4-9F54-04C0A4D97B12Q52613089-4B0A133D-89D0-440C-BE2B-A8F0BF260821Q53080352-D89E8890-1800-4C4E-A764-03C8DD09B5EE
P2860
Natural killer type 2 bias in remission of multiple sclerosis
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Natural killer type 2 bias in remission of multiple sclerosis
@ast
Natural killer type 2 bias in remission of multiple sclerosis
@en
Natural killer type 2 bias in remission of multiple sclerosis
@nl
type
label
Natural killer type 2 bias in remission of multiple sclerosis
@ast
Natural killer type 2 bias in remission of multiple sclerosis
@en
Natural killer type 2 bias in remission of multiple sclerosis
@nl
prefLabel
Natural killer type 2 bias in remission of multiple sclerosis
@ast
Natural killer type 2 bias in remission of multiple sclerosis
@en
Natural killer type 2 bias in remission of multiple sclerosis
@nl
P2093
P2860
P356
P1476
Natural killer type 2 bias in remission of multiple sclerosis
@en
P2093
K Takahashi
M Hatakenaka
S Hashimoto
T Yamamura
P2860
P356
10.1172/JCI11819
P407
P577
2001-03-01T00:00:00Z